三月二十九日夜间，英矽智能（港股代码：03696）正式宣布与礼来公司达成战略协作：协议包含1.15亿美元预付款，整体交易规模高达27.5亿美元，同时涵盖药物上市后的销售提成。合作焦点集中于一款临床前阶段的口服GLP-1药物；依托英矽智能的Pharma AI技术体系，双方还将针对礼来指定的多个靶点展开深度研发。
Young-Ho Kim, NAVER
。业内人士推荐zoom下载作为进阶阅读
At the time of writing, wafers containing the Baochip-1x design have been fabricated, and hundreds of the chips have been handed out through an early sampling program. These engineering samples were all hand-screened by me.
Establish U2F device rules:
Representations and Composition of Thinnings